The agreement begins November 1, 2016, and extends through October 31, 2019.
The Polysite® Low Profile Hybrid Ports are designed to enhance patient comfort while simultaneously providing clinicians with unique product enhancements.
The low-profile design incorporates hybrid technology with a durable titanium reservoir and a lightweight atraumatic-angled shell. The ports have a large septum for easy access and include a radiopaque locking collar for safe attachment to catheters.
They are available in both pressure-injectable and non-pressure-injectable options in 6Fr, 7Fr and 8Fr sizes.
“Arrow® Interventional Access products from Teleflex provide economical solutions and help clinicians to reduce complications,” said Jay White, President and General Manager, Vascular Division of Teleflex.
“We’re pleased to offer Premier members the clinical and financial benefits of the Polysite Ports under this new agreement.”
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose-driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers.
Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.
